tetano
Editor, Senior Moderator
Clin Microbiol Infect. 2015 Jun 25. pii: S1198-743X(15)00662-X. doi: 10.1016/j.cmi.2015.06.017. [Epub ahead of print]
[h=1]Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in southeastern France.[/h] Verger P[SUP]1[/SUP], Cortaredona S[SUP]2[/SUP], Pulcini C[SUP]3[/SUP], Casanova L[SUP]4[/SUP], Peretti-Watel P[SUP]2[/SUP], Launay O[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We studied a cohort of 110 823 patients treated with oral hypoglycaemic agents for type 2 diabetes in southeastern France from 1 January, 2008, to 31 December, 2011, to identify influenza vaccination coverage trends and the patient and physician correlates of influenza vaccine (IFV) uptake. We used French national health insurance fund (NHIF) databases to identify these patients and collect data on their IFV reimbursement claims (IFVC) and patient and physician characteristics. We used multilevel multivariate polytomous logistic regressions to test the correlates of IFVC. Between 2008 and 2011 the annual IFVC rate varied from 33.7% to 32.3% in the 18-64 age group and from 69.5% to 61.1% in the 65+ age group, among whom we saw a clear trend toward reduced vaccination after 2008. In the younger group, the probability of regular vaccination each year from 2008 to 2011 increased with diabetes severity and duration, comorbidities, and the number of GP and nurse visits; it was higher among patients seeing endocrinologists and lower among low-income patients than in other patients. In the older group, there was no association with either diabetes severity or physician specialty. These results suggest different patterns of correlates of influenza vaccination according to age. Endocrinologists might help to improve IFV uptake in the younger group of patients with type 2 diabetes. Communication strategies regarding influenza vaccination should be adapted to age, and collaboration between health-care professionals reinforced to achieve vaccination objectives for these patients.
Copyright ? 2015. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Care Management; Determinant; Diabetes Mellitus; Epidemiologic; Influenza Vaccine; Multilevel Analysis; Patient; Type 2; Vaccination
PMID: 26119723 [PubMed - as supplied by publisher]
[h=1]Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in southeastern France.[/h] Verger P[SUP]1[/SUP], Cortaredona S[SUP]2[/SUP], Pulcini C[SUP]3[/SUP], Casanova L[SUP]4[/SUP], Peretti-Watel P[SUP]2[/SUP], Launay O[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We studied a cohort of 110 823 patients treated with oral hypoglycaemic agents for type 2 diabetes in southeastern France from 1 January, 2008, to 31 December, 2011, to identify influenza vaccination coverage trends and the patient and physician correlates of influenza vaccine (IFV) uptake. We used French national health insurance fund (NHIF) databases to identify these patients and collect data on their IFV reimbursement claims (IFVC) and patient and physician characteristics. We used multilevel multivariate polytomous logistic regressions to test the correlates of IFVC. Between 2008 and 2011 the annual IFVC rate varied from 33.7% to 32.3% in the 18-64 age group and from 69.5% to 61.1% in the 65+ age group, among whom we saw a clear trend toward reduced vaccination after 2008. In the younger group, the probability of regular vaccination each year from 2008 to 2011 increased with diabetes severity and duration, comorbidities, and the number of GP and nurse visits; it was higher among patients seeing endocrinologists and lower among low-income patients than in other patients. In the older group, there was no association with either diabetes severity or physician specialty. These results suggest different patterns of correlates of influenza vaccination according to age. Endocrinologists might help to improve IFV uptake in the younger group of patients with type 2 diabetes. Communication strategies regarding influenza vaccination should be adapted to age, and collaboration between health-care professionals reinforced to achieve vaccination objectives for these patients.
Copyright ? 2015. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Care Management; Determinant; Diabetes Mellitus; Epidemiologic; Influenza Vaccine; Multilevel Analysis; Patient; Type 2; Vaccination
PMID: 26119723 [PubMed - as supplied by publisher]